Brief Description
Cure Glomerulonephropathy (CureGN) is a multicenter five-year observational study of glomerular disease patients.
Trial is for people with
Primary focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), membranous nephropathy (MN), and IgA nephropathy ...
Study Goal
The CureGN project will study 2,400 children and adults with the following glomerular diseases: minimal change disease (MCD), focal ...
What is involved for the patient?
Participants' health will be monitored over 5 years. This may require extra visits to your doctor.
Find other locations for this trial:
Chicago, IL